insights_auto
Why is CRVS up 4,53%?
Dive Deeperchevron_right
CRVS:NASDAQ
Corvus Pharmaceuticals Inc
9,80 $
arrow_upward
+4,53%(+0,43) 1D
15 қаз., 11:07:40 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CRVS...
Open
9,49 $
High
9,96 $
Low
9,36 $
Mkt. cap
825,23 млн
Avg. vol.
1,21 млн
Volume
191,62 м.
52-wk high
26,95 $
52-wk low
6,39 $
EPS
-0,62 $
Beta
1,44
Shares outstanding
84,12 млн
No. of employees
37
Open
9,49 $
High
9,96 $
Low
9,36 $
Mkt. cap
825,23 млн
Avg. vol.
1,21 млн
Volume
191,62 м.
52-wk high
26,95 $
52-wk low
6,39 $
EPS
-0,62 $
Beta
1,44
Shares outstanding
84,12 млн
No. of employees
37
News stories
From web sources and news partners
https://www.dars.gov.et/
·
6 күн бұрын
CRVS Q2 2026 Earnings: Wider-Than-Expected Loss Keeps Pre-Revenue Biotech in Focus - Financial Health Score
About Corvus Pharmaceuticals Inc
CEO-
Employees37
Founded2014
HeadquartersBurlingame, Калифорния, Америка Құрама Штаттары
Sector-
Websitecorvuspharma.com